Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

The document suggests changing medical education to balance generalists and specialists, focusing on patient needs.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

Costovertebral arthritis can cause chronic back pain in SLE patients and needs thorough evaluation.

Older men with late-onset lupus have a higher mortality rate than women.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Low-level laser therapy using near-infrared light may help heart conditions and promote healing by releasing nitric oxide.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Yale-New Haven Hospital won a top award for greatly improving asthma care and reducing related hospital visits and costs.

Low-level Laser Therapy may help reduce inflammation, pain, and aid healing, but more research is needed to confirm its effectiveness and establish standard treatment guidelines.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Researchers found two enzymes in Avicennia marina that help produce maslinic acid and corosolic acid, which have medicinal benefits.